Process for the preparation of 13-(Z)-retinoic acid

    公开(公告)号:DE4313089A1

    公开(公告)日:1994-10-27

    申请号:DE4313089

    申请日:1993-04-22

    Applicant: BASF AG

    Abstract: 13-(Z)-retinoic acid is prepared by a) reaction of 5-hydroxy-4-methyl-2-(5H)-furanone with a [3-methyl-5-(2,6,6-trimethyl-1-cyclohexene-1-yl)-2,4-pentadienyl] triarylphosphonium salt and b) subsequent partial isomerisation of the mixture of 13-(Z)- and 11,13-di-(Z)-retinoic acid obtained, characterised in that in reaction step a) the reaction is carried out in the presence of lithium hydroxide as alkali metal hydroxide and in dimethylformamide as solvent at temperatures from +10 to -9 DEG C and/or in reaction step b) the isomerisation is carried out by irradiation with light in the wavelength range between 200 and 600 nm of the isomer mixture obtained as in a) in an organic solvent in the presence of a photon sensitiser.

    144.
    发明专利
    未知

    公开(公告)号:DE4223889A1

    公开(公告)日:1994-01-27

    申请号:DE4223889

    申请日:1992-07-21

    Applicant: BASF AG

    Abstract: An improved process for preparing E,Z-butenedial bis(dialkyl acetals) by reacting the corresponding 2,5-dialkoxy-2,5-dihydrofurans with the corresponding lower alkanols in the presence of an acid at elevated temperature entails carrying out the reaction in the presence of approximately equimolar amounts of a trialkyl orthoformate and in the presence of catalytic amounts of a strong mineral acid or of a strong organic acid.

    145.
    发明专利
    未知

    公开(公告)号:DE4209616A1

    公开(公告)日:1993-09-30

    申请号:DE4209616

    申请日:1992-03-25

    Applicant: BASF AG

    Abstract: Process for the preparation of esters of beta -hydroxycarboxylic acids of the general formula I … … in which …… R and R denote C1- to C20-alkyl which is optionally substituted by C1- to C8-alkoxy and/or halogen; C3- to C20-alkoxycarbonylalkyl, C2- to C20-alkenyl, C5- to C30-acetylalkenyl, aryl which is optionally mono- to pentasubstituted by C1- to C8-alkyl, C1- to C8-alkoxy and/or halogen; C7- to C20-aralkyl, C7- to C20-aralkenyl, hetaryl, C3- to C20-cycloalkyl, C4- to C20-cycloalkylalkyl or, together, denote a C2- to C8-alkylene chain and R or R denotes hydrogen, … R denotes hydrogen, C1- to C20-alkyl, C2- to C20-alkenyl, aryl which is optionally mono- to pentasubstituted by C1- to C8-alkyl, C1- to C8-alkoxy and/or halogen; C7- to C20-aralkyl, C3- to C20-cycloalkyl or C4- to C20-cycloalkylalkyl, … R denotes C1- to C20-alkyl, C2- to C20-alkenyl, C7- to C20- aralkyl, C3- to C20-cycloalkyl or C4- to C20-cycloalkylalkyl, … by reaction of carbonyl compounds of the general formula II … … in which R and R have the abovementioned meanings, with esters of alpha -bromocarboxylic acids of the general formula III … … in which R and R have the abovementioned meanings, by carrying out the reaction with zinc in dichloromethane at temperatures from 0 to 50 DEG C, and a process for the preparation of esters of alpha -bromozinc-carboxylic acids of the general formula IV … … in which …… R denotes hydrogen, C1- to C20-alkyl, C2- to C20-alkenyl, aryl which is optionally mono- to pentasubstituted by C1- to C8-alkyl, C1- to C8-alkoxy and/or halogen; C7- to C20-aralkyl, C3- to C20-cycloalkyl or C4- to C20-cycloalkylalkyl, … R denotes C1- to C20-alkyl, C4- to C20-alkenyl, C7- to C20- aralkyl, C3- to C20-cycloalkyl or C4- to C20-cycloalkylalkyl, … from esters of alpha -bromocarboxylic acids of the general formula III according to Claim 1, which is characterised in that the reaction with zinc in dichloromethane is carried out at temperatures from 0 to 50 DEG C and the use of dichloromethane for the stable storage of the esters of alpha -bromozinc-carboxylic acids IV.

    146.
    发明专利
    未知

    公开(公告)号:DE3877423D1

    公开(公告)日:1993-02-25

    申请号:DE3877423

    申请日:1988-06-08

    Applicant: BASF AG

    Abstract: Ethyl 4-(O,O-dialkylphosphono) tiglates of formula (Ia) are new (where R1 = 1-4C alkyl). Tiglates (I) are produced by (a) reacting an alkyl 2-methyl-3-butenoate of formula (II) with Cl2 or Br2 in the absence of solvent; (b) reacting the resulting 3,4-dihalo-2-methylbutyrate of formula (III) with an alkali metal hydroxide in R2OH or R2OH/H2O; (c) reacting the resulting alkyl 4-halotiglate (E/Z isomer mixt.) of formula (IV) with a trialkyl phosphite of formula (V); and (d) thermally isomerising the prod. (In the formulae R2 = 1-3C alkyl; X = Cl or Br). Prodn. of cpds. (IV) is also claimed.

    147.
    发明专利
    未知

    公开(公告)号:DE3876483D1

    公开(公告)日:1993-01-21

    申请号:DE3876483

    申请日:1988-04-16

    Applicant: BASF AG

    Abstract: Conversion of pentose or hexose sugars (I) with a 2,3-cis configuration to the corresp. sugars (II) with a 2,3-trans configuration is effected by continuously passing a soln. of (I) in aq. MeOH or EtOH through a tube contg. a basic ion exchanger loaded with a hexavalent Mo cpd. in the absence of boric acid cpds.

    149.
    发明专利
    未知

    公开(公告)号:DE3583094D1

    公开(公告)日:1991-07-11

    申请号:DE3583094

    申请日:1985-09-10

    Applicant: BASF AG

    Abstract: 2-Amino-3,5-di-(halomethyl)-pyrazines of the general formula I (I) where X is either chlorine or bromine, m and n may each be 0, 1, 2 or 3 and R1 and R2 are each hydrogen or a protective group or may furthermore be bonded to one another, in particular those compounds of the formula I in which m is 1 and n is 2 and/or R1 and R2 together form a phthaloyl radical, are useful intermediates for the pteridine building block of folic acid or folic acid analogs. They are obtained by a method in which a 2-amino-3,5-dimethylpyrazine of the general formula II (II) is treated with a chlorinating or brominating agent and, where R1 and/or R2 are protective groups, these are, if desired, eliminated when the chlorination or bromination is complete.

Patent Agency Ranking